对于犬类认知功能障碍的诊断和治疗策略的最新进展
American journal of veterinary research
|April 29, 2025
概括
狗的认知功能障碍 (CCD) 是老年狗中诊断不足的一种神经退行性疾病,与阿尔茨海默氏症病理有共同之处. 对共享机制的研究为狗和人类提供了潜在的治疗方法.
科学领域:
- 兽医神经学 兽医神经学
- 神经退行性疾病 神经退行性疾病
- 比较病理学比较病理学
背景情况:
- 狗的认知功能障碍 (CCD) 是老年狗中普遍存在的一种神经退行性疾病,表现为失方向和焦虑等症状.
- 由于缺乏客观的诊断工具和有限的治疗选择,CCD的诊断往往不足.
- 在病理上,CCD反映了人类的阿尔茨海默病,包括β-粉样蛋白积累,蛋白酸化,神经元损失和神经炎症.
研究的目的:
- 审查目前对CCD病理学的理解.
- 讨论CCD新出现的诊断和治疗方面的进展.
- 探索狗和人类神经退行性疾病之间共享治疗点的潜力.
主要方法:
- 对最近有关犬类认知功能障碍的研究进行文献综述.
- 分析CCD和阿尔茨海默病之间的共同病理特征.
- 检查当前和未来的诊断和治疗策略.
主要成果:
- CCD与阿尔茨海默病的关键病理有共同之处,包括β-粉样质斑块和脑粉样质血管病变.
- 大脑粉样血管病变导致血管功能障碍,缺氧和神经炎症,恶化认知能力下降.
- 了解这些共同的途径为新的治疗干预打开了道路.
结论:
- 慢性痴呆症是狗中显著的神经退行性疾病,与人类阿尔茨海默病有相似之处.
- 诊断和治疗方面的进步对于改善犬类认知功能障碍的结果至关重要.
- 对比研究对开发有利于两种物种的治疗方法充满希望.
相关概念视频
Alzheimer's Disease: Overview
315
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
315
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
85
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
85
Alzheimer's Disease: Treatment
128
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
128
Dementia
64
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
64
Cognitive Development During Adulthood
22
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
22


